16.00
0.00
(0.00%)
At close: January 30 at 9:59:02 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 18 | 8 | 26 | 26 |
| Avg. Estimate | 14.83B | 13.13B | 56.04B | 59.07B |
| Low Estimate | 14.6B | 12.81B | 55.56B | 56.8B |
| High Estimate | 15.02B | 13.72B | 56.27B | 60.42B |
| Year Ago Sales | 14.3B | 12.31B | 54.32B | 56.04B |
| Sales Growth (year/est) | 3.68% | 6.67% | 3.18% | 5.40% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 4AB0.F | -- | -- | -- | -- |
| S&P 500 | 9.01% | 10.57% | 14.00% | 13.70% |
Related Tickers
GS71.DU GSK PLC
16.81
+0.54%
AMG.HA Amgen Inc
271.15
+0.37%
BRM.MU Bristol-Myers Squibb Co
56.50
+0.34%
AMGN.MX Amgen Inc.
5,835.99
+1.34%
0O59.IL Sanofi
103.61
+2.01%
SANO.VI Sanofi
103.38
+1.55%
SNW.F Sanofi
103.28
+1.37%
KLBF.JK PT Kalbe Farma Tbk.
1,250.00
+1.21%
4503.T Astellas Pharma Inc.
1,515.50
-0.88%
ZEG.DE AstraZeneca PLC
135.60
+0.74%